X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5418) 5418
Book Chapter (111) 111
Dissertation (19) 19
Newspaper Article (13) 13
Publication (11) 11
Government Document (6) 6
Book / eBook (4) 4
Magazine Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4093) 4093
humans (4068) 4068
life sciences & biomedicine (3949) 3949
male (3933) 3933
prostate cancer (3015) 3015
oncology (2282) 2282
prostatic neoplasms, castration-resistant - drug therapy (1876) 1876
prostatic neoplasms, castration-resistant - pathology (1595) 1595
aged (1364) 1364
castration-resistant prostate cancer (1254) 1254
metastasis (1178) 1178
middle aged (1166) 1166
urology & nephrology (1160) 1160
cancer (1077) 1077
animals (863) 863
treatment outcome (855) 855
cell line, tumor (850) 850
chemotherapy (802) 802
aged, 80 and over (796) 796
prostatic neoplasms, castration-resistant - metabolism (790) 790
care and treatment (754) 754
antineoplastic agents - therapeutic use (713) 713
prostatic neoplasms, castration-resistant - genetics (703) 703
castration (688) 688
prostate (642) 642
androgens (631) 631
neoplasm metastasis (604) 604
prostatic neoplasms - pathology (576) 576
docetaxel (557) 557
receptors, androgen - metabolism (548) 548
androgen receptor (545) 545
prostatic neoplasms - drug therapy (544) 544
disease progression (539) 539
urology (536) 536
analysis (523) 523
prognosis (507) 507
mice (504) 504
research (501) 501
phenylthiohydantoin - analogs & derivatives (498) 498
metastases (473) 473
prostate-specific antigen - blood (464) 464
cancer therapies (450) 450
retrospective studies (441) 441
bone neoplasms - secondary (434) 434
urologic and male genital diseases (427) 427
prostatic neoplasms, castration-resistant - mortality (415) 415
enzalutamide (411) 411
antineoplastic combined chemotherapy protocols - therapeutic use (410) 410
receptors, androgen - genetics (409) 409
cell biology (407) 407
taxoids - therapeutic use (405) 405
development and progression (396) 396
disease-free survival (379) 379
prostatic neoplasms, castration-resistant - blood (379) 379
endocrinology & metabolism (375) 375
patients (367) 367
pharmacology & pharmacy (366) 366
androgen antagonists - therapeutic use (362) 362
health aspects (346) 346
tumors (346) 346
medicine & public health (342) 342
abiraterone (334) 334
prostatic neoplasms - metabolism (332) 332
drug therapy (326) 326
drug resistance, neoplasm (325) 325
prostatic neoplasms, castration-resistant - therapy (325) 325
gene expression (317) 317
abiraterone acetate (316) 316
signal transduction (295) 295
metastatic castration-resistant prostate cancer (294) 294
gene expression regulation, neoplastic (281) 281
phenylthiohydantoin - therapeutic use (281) 281
clinical trials (280) 280
taxoids - administration & dosage (280) 280
antineoplastic agents - pharmacology (275) 275
survival (272) 272
biochemistry & molecular biology (261) 261
adult (259) 259
apoptosis (257) 257
prostate-specific antigen (256) 256
survival analysis (250) 250
hematology, oncology and palliative medicine (247) 247
castration resistant prostate cancer (243) 243
cabazitaxel (242) 242
castration-resistant (241) 241
proteins (239) 239
orchiectomy (238) 238
prostatic neoplasms - genetics (236) 236
immunotherapy (233) 233
xenograft model antitumor assays (232) 232
cell proliferation - drug effects (231) 231
genetic aspects (230) 230
signal transduction - drug effects (223) 223
antigens (221) 221
kaplan-meier estimate (217) 217
medical research (212) 212
antineoplastic agents - administration & dosage (211) 211
quality of life (210) 210
antineoplastic agents (206) 206
antineoplastic agents, hormonal - therapeutic use (205) 205
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5363) 5363
German (83) 83
Japanese (67) 67
Spanish (56) 56
French (42) 42
Chinese (37) 37
Russian (37) 37
Czech (12) 12
Hungarian (10) 10
Norwegian (4) 4
Portuguese (4) 4
Danish (3) 3
Dutch (3) 3
Italian (2) 2
Turkish (2) 2
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European urology, ISSN 0302-2838, 04/2017, Volume 71, Issue 4, pp. 630 - 642
Journal Article
Nature (London), ISSN 1476-4687, 03/2017, Volume 543, Issue 7647, pp. 728 - 732
A significant fraction of patients with advanced prostate cancer treated with androgen deprivation therapy experience relapse with relentless progression to lethal metastatic castration-resistant prostate cancer (mCRPC)(1... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Anilides - therapeutic use | Immunotherapy - methods | Humans | Prostatic Neoplasms, Castration-Resistant - immunology | Male | Myeloid-Derived Suppressor Cells - drug effects | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Prostatic Neoplasms, Castration-Resistant - pathology | Quinolines - pharmacology | Myeloid-Derived Suppressor Cells - cytology | Prostatic Neoplasms, Castration-Resistant - therapy | Female | Imidazoles - therapeutic use | Cytokines - immunology | Disease Models, Animal | Pyridines - therapeutic use | Tumor Microenvironment - drug effects | Myeloid-Derived Suppressor Cells - immunology | Cytokines - metabolism | Imidazoles - pharmacology | Lymphocytes, Tumor-Infiltrating - drug effects | Drug Synergism | Tumor Microenvironment - immunology | Animals | Signal Transduction - drug effects | CD8-Positive T-Lymphocytes - drug effects | Anilides - pharmacology | Mice | Pyridines - pharmacology | Quinolines - therapeutic use | CD8-Positive T-Lymphocytes - immunology | Chimera | Lymphocytes, Tumor-Infiltrating - immunology | Care and treatment | Metastasis | Prostate cancer | Analysis | Immunotherapy | Patient outcomes | Cancer therapies | Tumors | Index Medicus
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2019, Volume 380, Issue 13, pp. 1235 - 1246
Journal Article